CTSD is the key therapeutic target of Jinshui Liujun decoction in treating chronic bronchitis

This study used network pharmacology, bioinformatics, molecular docking and molecular dynamics simulations to evaluate the pharmacological mechanism of Jinshui Liujun decoction in treating chronic bronchitis. The network pharmacology constructed and analysed the drug-disease targets network. Microarray data analysis revealed CTSD as a key therapeutic target gene. Molecular docking and molecular dynamics simulations results indicated CTSD, can bind with β-sitosterol, cerevisterol, stigmasterol effectively. This study identifies the mechanism of action and gene expression of the key therapeutic target CTSD of Jinshui Liujun decoction in the treatment of chronic bronchitis, and verifies its binding stability with the key active components, aiming to provide new targets and research directions for the clinical treatment of chronic bronchitis.

Authors

Institutions

Publication Details

Journal
Natural Product Research
Published
2024-10-27
DOI
https://doi.org/10.1080/14786419.2024.2420339
Primary Topic
Respiratory and Cough-Related Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CTSD is the key therapeutic target of Jinshui Liujun decoction in treating chronic bronchitis

Chen Shen, Wenshu Luo, Zhenjun Chen, Xinyi Chen et al.
Natural Product Research
Respiratory and Cough-Related Research
article

CTSD is the key therapeutic target of Jinshui Liujun decoction in treating chronic bronchitis

Chen Shen, Wenshu Luo, Zhenjun Chen, Xinyi Chen, Fuxia Yang, Xuekang Su, Tian Xie, Zhen Nong, Chuanshen Gu
article en

Abstract

This study used network pharmacology, bioinformatics, molecular docking and molecular dynamics simulations to evaluate the pharmacological mechanism of Jinshui Liujun decoction in treating chronic bronchitis. The network pharmacology constructed and analysed the drug-disease targets network. Microarray data analysis revealed CTSD as a key therapeutic target gene. Molecular docking and molecular dynamics simulations results indicated CTSD, can bind with β-sitosterol, cerevisterol, stigmasterol effectively. This study identifies the mechanism of action and gene expression of the key therapeutic target CTSD of Jinshui Liujun decoction in the treatment of chronic bronchitis, and verifies its binding stability with the key active components, aiming to provide new targets and research directions for the clinical treatment of chronic bronchitis.

Natural Product ResearchVol. 40(5)
Guangzhou University of Chinese Medicine (CN), Guangxi University (CN), First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN), Guangxi University of Chinese Medicine (CN), Shenzhen Pingle Orthopedic Hospital (CN)
Sanming Project of Medicine in Shenzhen
Good health and well-being
Openalex Percentile: Top 65%
Respiratory and Cough-Related Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CTSD is the key therapeutic target of Jinshui Liujun decoction in treating chronic bronchitis — Chen Shen, Wenshu Luo, et al. · Natural Product Research (2024) | TGRS Research Map | TGRS